Skip to content

daVinci Digital Therapeutics

Search for:

Home
DTx Blog
News
Pipeline
Events
DTxDay21
Contact us

Home
DTx Blog
News
Pipeline
Events
DTxDay21
Contact us

Search for:

daVinci Digital Therapeutics

a Digital Biotech Company

Digital Health

Protected: An Italian Law for Digital Health?

by daVinciDTx · Published 18 July 2021 · Updated 18 November 2021

This content is password protected. To view it please enter your password below:

Password:

You may also like...

What are DTx Digital Excipients?
23 August 2020
by daVinciDTx · Published 23 August 2020 · Last modified 24 August 2020
Italy accelerates the path towards digital therapeutics implementation
10 April 2021
by daVinciDTx · Published 10 April 2021
“Apps” for the patient – Medical devices or toys?
31 October 2021
by daVinciDTx · Published 31 October 2021 · Last modified 18 November 2021

Recent Posts

Digital Therapeutics Day 2021 – Introduction
Digital Therapeutics Day 2021
An Italian Law for Digital Health?
Digital Health “Made in Italy”
“Apps” for the patient – Medical devices or toys?
Protected: Evolution of Patient Roles in Therapeutic Research of Drugs and Digital Therapeutics
Protected: An Italian Law for Digital Health?
How can Digital Therapeutics enter medical practice if Digital Medicine doesn’t?
Italy accelerates the path towards digital therapeutics implementation
Digital Therapeutics – Tonic or Poison for Pharmaceutical companies?
White paper reveals pathway for digital therapeutics use in Italy
Digital Therapeutics, an Opportunity for Italy
Digital Therapeutics Day 2020 – Where Are We Now? We Are We Going?
Startup – Corporate collaboration to develop DTx
What are DTx Digital Excipients?
The New Era of Programmable Medicines
Programmable Medicines and Digital Biotechnology
Digital Therapeutics – What They Are, What They Will Be
Digital Therapeutic to Treat Adjustment Disorders during COVID-19
FDA has approved Somryst, a Digital Therapeutic to treat chronic insomnia

daVinci Digital Therapeutics srl, Milan 2020